Daniela Gabbia - Department of Pharmaceutical and Pharmacological Sciences (S.D.M., University of Padova

基本信息

浏览量：31

职业迁徙

个人简介

Daniela Gabbia currently works at the Department of Pharmaceutical and Pharmacological Sciences DSF, University of Padova. Daniela's fields of interest are natural product, pharmacokinetic and toxicokinetics and liver diseases.

研究兴趣

论文共 98 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Insights into Hepatocellular Carcinoma: from Pathophysiology to Novel Therapies

Daniela Gabbia,Sara De Martin

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES（2024）

引用0浏览0WOS引用

Tyrosol Attenuates NASH Features by Reprogramming the Hepatic Immune Milieu

Daniela Gabbia,Katia Sayaf,Ilaria Zanotto,Martina Colognesi,Yahima Frion-Herrera,Maria Carrara,Francesco Paolo Russo,Sara De Martin

EUROPEAN JOURNAL OF PHARMACOLOGY (2024)

引用0浏览0WOS引用

Current Perspectives on the Molecular and Clinical Relationships between Primary Biliary Cholangitis and Hepatocellular Carcinoma

Annarosa Floreani,Daniela Gabbia,Sara De Martin

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESno. 4 (2024): 2194

引用0浏览0WOS引用

Supplementary Figure6 from Adipocyte Precursor-Derived NRG1 Promotes Resistance to FGFR Inhibition in Urothelial Carcinoma

Sana Hosni, Viola Kilian,Niklas Klümper,Daniela Gabbia,Katharina Sieckmann,Dillon Corvino, Anja Winkler,Miriam Saponaro, Karin Wörsdörfer,Doris Schmidt,Oliver Hahn,Ilaria Zanotto, Marina Bertlich,Marieta Toma,Tobias Bald,Markus Eckstein,Michael Hölzel,Matthias Geyer,Manuel Ritter,Dagmar Wachten,Sara De Martin,Abdullah Alajati

crossref（2024）

引用0浏览0引用

Current Perspectives on the Molecular and Clinical Relationships Between Primary Biliary Cholangitis and Hepatocellular Carcinoma

Annarosa Floreani,Daniela Gabbia,Sara De Martin

International Journal of Molecular Sciencesno. 4 (2024): 2194

引用0浏览0引用

Optimization of a Pendant-Shaped PEGylated Linker for Antibody-Drug Conjugates

T. Tedeschini, B. Campara,A. Grigoletto,I. Zanotto, L. Cannella,D. Gabbia, Y. Matsuno, A. Suzuki, H. Yoshioka,A. Armirotti,S. De Martin,G. Pasut

JOURNAL OF CONTROLLED RELEASE (2024): 74-89

引用0浏览0WOS引用

Editorial: Women in Gastrointestinal and Hepatic Pharmacology 2022

Eleonora Lai,Jessica Williams,Raquel Abalo,Daniela Gabbia

Frontiers in pharmacology (2024): 1359135-1359135

引用0浏览0WOS引用

Liposomal Doxorubicin Targeted with the Fab’ of Atezolizumab Exerts an Immunomodulatory Effect in in Vitro Models of Hepatocellular Carcinoma

I. Zanotto,D. Gabbia,A. Grigoletto, M. Toffanin, V. Mazzucco,A. De Rossi,G. Pasut,S. De Martin

DIGESTIVE AND LIVER DISEASE (2024): S97-S97

引用0浏览0引用

Adipocyte Precursor-Derived NRG1 Promotes Resistance to FGFR Inhibition in Urothelial Carcinoma

Sana Hosni, Viola Kilian,Niklas Kluemper,Daniela Gabbia,Katharina Sieckmann,Dillon Corvino, Anja Winkler,Miriam Saponaro, Karin Woersdoerfer,Doris Schmidt,Oliver Hahn,Ilaria Zanotto, Marina Bertlich,Marieta Toma,Tobias Bald,Markus Eckstein,Michael Hoelzel,Matthias Geyer,Manuel Ritter,Dagmar Wachten,Sara De Martin,Abdullah Alajati

CANCER RESEARCH（2024）

引用0浏览0WOS引用

Are Gender Differences Important for Autoimmune Liver Diseases

Annarosa Floreani,Daniela Gabbia,Sara De Martin

Life（2024）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn